These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 27280231)
1. Liver aminotransferases in under-five HIV-positive children on HAART. Ajulo MO; Omole MK; Moody JO; Dixon-Umo OT; Salami OL Afr J Med Med Sci; 2015 Sep; 44(3):197-204. PubMed ID: 27280231 [TBL] [Abstract][Full Text] [Related]
2. Livolin ameliorates elevations in alanine transaminase in HIV infected patients commencing highly active antiretroviral therapy. Otegbayo JA; Kuti MA; Ogunbode O; Irabor AE; Adewoles IF Afr J Med Med Sci; 2012 Dec; 41(4):417-22. PubMed ID: 23672107 [TBL] [Abstract][Full Text] [Related]
3. Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine. Manfredi R; Calza L; Chiodo F HIV Clin Trials; 2005; 6(6):302-11. PubMed ID: 16452064 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of first antiretroviral regimen in HIV/hepatitis C virus co-infection. Cooper CL; Breau C; Laroche A; Lee C; Garber G HIV Med; 2006 Jan; 7(1):32-7. PubMed ID: 16313290 [TBL] [Abstract][Full Text] [Related]
6. Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat. Iacobellis G; Pellicelli AM; Grisorio B; Barbarini G; Leonetti F; Sharma AM; Barbaro G Obesity (Silver Spring); 2008 Jan; 16(1):179-83. PubMed ID: 18223632 [TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. Torti C; Lapadula G; Casari S; Puoti M; Nelson M; Quiros-Roldan E; Bella D; Pastore G; Ladisa N; Minoli L; Sotgiu G; Mazzotta F; Lo Caputo S; Di Perri G; Filice G; Tinelli C; Carosi G; BMC Infect Dis; 2005 Jul; 5():58. PubMed ID: 16018804 [TBL] [Abstract][Full Text] [Related]
8. Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya. Peters PJ; Stringer J; McConnell MS; Kiarie J; Ratanasuwan W; Intalapaporn P; Potter D; Mutsotso W; Zulu I; Borkowf CB; Bolu O; Brooks JT; Weidle PJ HIV Med; 2010 Nov; 11(10):650-60. PubMed ID: 20659176 [TBL] [Abstract][Full Text] [Related]
9. HAART and liver: is it safe? Antonello VS; Kliemann DA; Rigel Santos B; Tovo CV J Infect Dev Ctries; 2014 Nov; 8(11):1444-50. PubMed ID: 25390056 [TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study. Manosuthi W; Chumpathat N; Chaovavanich A; Sungkanuparph S BMC Infect Dis; 2005 Aug; 5():67. PubMed ID: 16120209 [TBL] [Abstract][Full Text] [Related]
11. Antiretroviral therapy-related hepatotoxicity: predictors and clinical management. Dore G J HIV Ther; 2003 Nov; 8(4):96-100. PubMed ID: 14671507 [TBL] [Abstract][Full Text] [Related]
12. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection. Aranzabal L; Casado JL; Moya J; Quereda C; Diz S; Moreno A; Moreno L; Antela A; Perez-Elias MJ; Dronda F; Marín A; Hernandez-Ranz F; Moreno A; Moreno S Clin Infect Dis; 2005 Feb; 40(4):588-93. PubMed ID: 15712082 [TBL] [Abstract][Full Text] [Related]
13. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity. Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ; Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: impact of hepatitis C coinfection. French AL; Benning L; Anastos K; Augenbraun M; Nowicki M; Sathasivam K; Terrault NA Clin Infect Dis; 2004 Aug; 39(3):402-10. PubMed ID: 15307009 [TBL] [Abstract][Full Text] [Related]